Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. financial statements

Sonoma Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 19.53M10-K
Net income−USD 3.17M10-K
Cash and equivalentsUSD 2.4M10-Q
Total debtUSD 842KEODHD

Sonoma Pharmaceuticals, Inc. financials on 6ix · Sonoma Pharmaceuticals, Inc. on 6ix